基本资料 投资组合 财务数据 基金公告
汇添富创新医药混合C(024344) |
净值：
1.6359
|
日增长率：
0.76%
|
累计净值：1.6359 | 2026-09-18 |
|
|
||||
| 股票代码 | 股票简称 | 持股数量(股) | 持股市值(元) | 占基金净值比(%) |
| 600276 | 恒瑞医药 | 22,298,323.00 | 1,160,404,728.92 | 9.78 |
| 06990 | 科伦博泰生物 | 2,941,000.00 | 1,114,231,700.91 | 9.39 |
| 01530 | 三生制药 | 74,629,500.00 | 1,094,800,548.08 | 9.22 |
| 01801 | 信达生物 | 15,798,500.00 | 1,092,254,259.13 | 9.20 |
| 002653 | 海思科 | 15,377,635.00 | 1,020,152,305.90 | 8.59 |
| 688506 | 百利天恒 | 3,415,423.00 | 1,004,236,824.69 | 8.46 |
| 01093 | 石药集团 | 162,340,000.00 | 982,772,836.79 | 8.28 |
| 688266 | 泽璟制药 | 6,024,877.00 | 702,862,150.82 | 5.92 |
| 300765 | 石药创新 | 15,176,574.00 | 413,258,110.02 | 3.48 |
| 688382 | 益方生物 | 16,060,707.00 | 289,092,726.00 | 2.44 |
| 报告期 | 股票占净比(%) | 债券占净比(%) | 现金占净比(%) | 净资产(元) |
| 2026-06-30 | 90.81 | - | 10.22 | 11,870,285,969.97 |
| 2026-03-31 | 89.74 | - | 10.97 | 12,126,186,595.65 |
| 2025-12-31 | 90.51 | - | 10.04 | 11,881,367,144.28 |
| 2025-09-30 | 93.82 | - | 6.52 | 13,473,977,322.85 |
| 2025-06-30 | 92.61 | 0.01 | 9.10 | 9,275,735,452.13 |
微信公众号
证券之星APP
